Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection

Introduction The COVID-19 epidemic grows and there are clinical trials of antivirals. There is an opportunity to complement these trials with investigation of angiotensin II type 1 receptor blockers (ARBs) because an ARB (losartan) was effective in murine influenza pneumonia.Methods and analysis Our...

詳細記述

書誌詳細

主要な著者:	Joel Singer, Srinivas Murthy, Bin Du, Terry Lee, Michael O Harhay, John C Marshall, Zhiyong Peng, James A. Russell, Arthur Slutsky, Dave Sweet, David M Patrick, Matthew Cheng, Kevin D Burns
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMJ Publishing Group 2020-12-01
シリーズ:	BMJ Open
オンライン･アクセス:	https://bmjopen.bmj.com/content/10/12/e040768.full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!